Natco Pharma has acquired all minority shares of South Africa’s Adcock Ingram for approximately $215 million. Adcock, valued at $645 million, has a rich history since its 1950 JSE listing. Despite past ownership changes, Bidvest Group retains majority control. The acquisition ends Adcock’s minority status.
Read more@
